362 matches for your search in the start-up spotlight
rss
Innovate Nordics targets Nordic growth companies aiming to establish a presence in the U.S. market
30-Apr-2025
Neogap Therapeutics, a Swedish biotechnology start-up developing personalised immunotherapy for cancer treatment, announced that it has been selected for the Innovate Nordics 2025 Acceleration Program, organised by the Swedish-American Chamber of Commerce in New York (SACCNY) in partnership with ...
Breakthrough antibody therapies target the roots of inflammation and promise breakthroughs for millions of patients
30-Apr-2025
Granite Bio AG has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures. Granite’s pipeline features two first-in-class antibodies ...
Funding from SPRIND and Family Offices
22-Apr-2025
AATec Medical GmbH (AATec), a biotech company developing a multi-product platform for the treatment of respiratory diseases based on recombinant alpha-1 antitrypsin (AAT), announced that it has secured EUR 4 million in a pre-series A financing from Germany’s Federal Agency for Disruptive ...
New Veganz Group subsidiary with 40 million valuation - investor entry expected in Q2/2025
16-Apr-2025
Veganz Group AG founded OrbiFarm GmbH on April 10, 2025 in order to leverage hidden reserves within the company. The purpose of the company is the research, development, patenting, production, distribution and licensing of indoor farming technologies. The focus is on the cultivation of protein ...
Improving the development of mRNA therapeutics
04-Apr-2025
Wacker Biotech, a contract development and manufacturing organization (CDMO) wholly owned by Wacker Chemie AG, announced a strategic collaboration with RNAV8 Bio, a Boston-based pioneer in mRNA engineering. The collaboration is aimed at progressing the development and production of mRNA-based ...
eversyn's technology could revolutionize the development of nutritional products and biopharmaceuticals
27-Mar-2025
eversyn, a spin-off of the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully raised €1.6 million in seed capital to advance its innovative technology applications in the fields of nutrition and biopharmaceuticals. This investment follows a €1.1 million ...
Combating menstrual pain through local application of very low doses of painkillers addresses high unmet medical need
25-Mar-2025
Meliodays Medical GmbH, a young pharmaceutical company focusing on the development of a new therapy for the hormone-free and locally acting treatment of menstrual pain, today announces the successful closing of an oversubscribed pre-seed financing round of over 800,000 euros led by capacura GmbH ...
Start-up prize for "EmbryoNet AI Technologies"
25-Mar-2025
Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for ...
Shorten research and development time for cancer drugs from 3 years to 12 months and significantly reduce development costs
24-Mar-2025
The German-Swiss biotechnology start-up BioCopy has secured new capital of 8 million euros. This sum is an important step for the company on its mission to produce more effective cancer drugs in the shortest possible time and at significantly lower costs. The company is supported by a group of ...
LMU spin-off receives multi-million euro EU grant
24-Mar-2025
LMU scientist Olivia Merkel researches nanocarriers for the targeted delivery of drugs to their site of action. Now the company she co-founded, RNhale, has been awarded a lucrative EU grant to bring a new anti-asthma therapy to clinical readiness. The company name describes the envisioned product ...
